Search This Blog

Saturday, June 27, 2026

Viridian FDA OK for Lumvoa for thyroid eye disease, its first commercial product

 

Viridian Therapeutics wins FDA approval for Lumvoa for thyroid eye disease, its first commercial product

  • U.S. launch of Lumvoa (veligrotug-vvze) for thyroid eye disease begins immediately following FDA approval
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)